BioMarin Pharmaceutical, Inc. (BMRN)
60.36
-0.22
(-0.35%)
USD |
NASDAQ |
Mar 06, 10:18
BioMarin Pharmaceutical Market Cap : 11.61B for March 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.501B |
| Gilead Sciences, Inc. | 179.04B |
| Merck & Co., Inc. | 283.29B |
| MannKind Corp. | 829.09M |
| AbbVie, Inc. | 404.07B |
Market Cap Related Metrics
| PE Ratio | 33.87 |
| PS Ratio | 3.620 |
| Price to Book Value | 1.907 |
| Price to Free Cash Flow | 16.37 |
| Price | 60.36 |
| Earnings Yield | 2.95% |
| Operating PE Ratio | 14.36 |
| Normalized PE Ratio | 18.95 |